Corticobasal degeneration: Neuropathologic and clinical heterogeneity

Neurology

Volumn 48, Issue 4, 1997, Pages 959-969

  Schneider, J A ^a   Watts, R L ^a   Gearing, M ^a   Brewer, R P ^a   Mirra, S S ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; AMNESIA; APRAXIA; ARTICLE; BRAIN DEGENERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GAIT DISORDER; HUMAN; HUMAN TISSUE; LIMB DISEASE; MALE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SPEECH DISORDER;

EID: 0030908014     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.48.4.959     Document Type: Article

References (58)

1. Chen J-Y, Stern Y, Sano M, Mayeux R. Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. Arch Neurol 1991;48:1141-1143.
2. Morris JC, Drazner M, Fulling K, Grant EA, Goldring J. Clinical and pathologic aspects of parkinsonism in Alzheimer's disease: a role for extranigral factors? Arch Neurol 1989;46: 651-657.
3. Mayeux R, Denaro J, Hemenegildo N, et al. A population-based investigation of Parkinson's disease with and without dementia: relationship to age and gender. Arch Neurol 1992; 49:492-497.
4. Marder K, Tang M, Cote L, Stern Y, Mayeux R. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol 1995;52:695-701.
5. Ditter SM, Mirra SS. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 1987;37:754-760.
6. Hulette C, Mirra S, Wilkinson W, Heyman A, Fillenbaum G, Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease. Neurology 1995;45:1991-1995.
7. Dickson DW, Davies P, Mayeux R, et al. Diffuse Lewy body disease: neuropathological and biochemical studies of six patients. Acta Neuropathol (Berl) 1987;75:8-15.
8. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990;40:1-8.
9. Boller F, Mizutani T, Roessmann U, Gambetti P. Parkinson disease, dementia, and Alzheimer disease: clinicopathologic correlations. Ann Neurol 1980;7:329-335.
10. Hakim AM, Mathieson G. Basis of dementia in Parkinson's disease [letter]. Lancet 1978;1:729.
11. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55:181-184.
12. Gearing M, Olson DA, Watts RL, Mirra SS. Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology 1994;44:1015-1024.
13. Gibb WRG, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989;112:1171-1192.
14. Ikeda K, Akiyama H, Haga C, Kondo H, Arima K, Oda T. Argyrophilic thread-like structure in corticobasal degeneration and supranuclear palsy. Neurosci Lett 1994;174:157-159.
15. Jendroska K, Rossor MN, Mathias CJ, Daniel SE. Morphological overlap between corticobasal degeneration and Pick's disease: a clinicopathological report. Mov Disord 1995;10:111-114.
16. Feany MB, Mattiace LA, Dickson DW. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease, and corticobasal degeneration. J Neuropathol Exp Neurol 1996;55: 53-67.
17. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44: 2015-2019.
18. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55:97-105.
19. Mori H, Nishimura M, Namba Y, Oda M. Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Acta Neuropathol (Berl) 1994;88:113-121.
20. Horoupian DS, Chu PL. Unusual case of corticobasal degeneration with tau/Gallyas-positive neuronal and glial tangles. Acta Neuropathol (Berl) 1994;88:592-598.
21. Uchihara T, Mitani K, Mori H, Kondo H, Yamada M, Ikeda K. Abnormal cytoskeletal pathology peculiar to corticobasal degeneration is different from that of Alzheimer's disease or progressive supranuclear palsy. Acta Neuropathol (Berl) 1994; 88:379-383.
22. Ksiezak-Reding H, Morgan K, Mattiace LA, et al. Ultrastructural and biochemical composition of paired helical filaments in corticobasal degeneration. Am J Pathol 1994;145:1496-1508.
23. Feany MB, Ksiezak-Reding H, Liu WK, Vicent I, Yen SHC, Dicksen DW. Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy. Acta Neuropathol (Berl) 1995; 90:37-43.
24. Feany MB, Dickson DW. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 1995; 146:1388-1396.
25. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to beta-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
26. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
27. Schneider JA, Gearing M, Robbins RS, de l'Aune W, Mirra SS. Apolipoprotein E genotype in diverse neurodegenerative disorders. Ann Neurol 1995;38:131-135.
28. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. Arch Neurol 1964;10:333-359.
29. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
30. Gearing M, Schneider JA, Rebeck GW, Hyman BT, Mirra SS. Alzheimer's disease with and without Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates. Neurology 1995;45:1985-1990.
31. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
32. Rinne JO, Lee MS, Thompson PD, Marsden CD. Corticobasal degeneration: a clinical study of 36 cases. Brain 1994;117: 1183-1196.
33. Sawle GV, Brooks DJ, Marsden CD, Frackowiak RSJ. Corticobasal degeneration: a unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain 1991;114: 541-556.
34. Gibb WR Neuropathology of Parkinson's disease and related syndromes [review]. Neurol Clin 1992;10:361-376.
35. Watts RL, Mirra SS, Richardson EP. Corticobasal ganglionic degeneration. In: Marsden CD, Fahn S, eds. Movement disorders 3 Oxford: Butterworth-Heinemann, 1994:282-299.
36. Vidailhet M, Rivaud S, Gouider-Khouja N, et al. Eye movements in parkinsonian syndromes. Ann Neurol 1994;35:420-426.
37. Pillon B, Blin J, Vidailhet M, et al. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 1995;45:1477-1483.
38. Lippa CF, Smith TW, Fontneau N. Corticonigral degeneration with neuronal achromasia: a clinicopathologic study of two cases J Neurol Sci 1990;98:301-310.
39. Lippa CF, Cohen R, Smith TW, Drachman DA. Primary progressive aphasia with focal neuronal achromasia. Neurology 1991;41:882-886.
40. Thompson PD, Marsden CD. Corticobasal degeneration. Baillieres Clin Neurol 1992;1:677-686.
41. Rey GJ, Tomer R, Levin BE, Sanchez-Ramos J, Bowen B, Bruce JH. Psychiatric symptoms, atypical dementia, and left visual field inattention in corticobasal ganglionic degeneration Mov Disord 1995;10:106-110.
42. Massman PJ, Kreiter KT, Jankovic J, Doody RS. Neuropsychological functioning in cortical-basal ganglionic degeneration: differentiation from Alzheimer's disease. Neurology 1996;46:720-726.
43. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathological study. Neurology 1997;48:119-125.
44. Dickson DW, Yen S-H, Suzuki KI, Davies P, Garcia JH. Hirano A. Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes. Acta Neuropathol (Berl) 1986;71:216-223.
45. Nakazato Y, Hirato J, Ishida Y, Hoshi S, Hasegawa M, Fukuda T. Swollen cortical neurons in Creutzfeldt-Jakob disease contain a phosphorylated neurofilament epitope. J Neuropathol Exp Neurol 1990;49:197-205.
46. Mackenzie IRA, Hudson LP. Achromatic neurons in the cortex of progressive supranuclear palsy. Acta Neuropathol (Berl) 1995;90:615-619.
47. Manetto V, Sternberger NH, Petty G, Sternberger LA, Gambetti P. Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1986;47: 642-653.
48. Nishimura T, Ikeda K, Akiyama H, et al. Immunohistochemical investigation of tau-positive structures in the cerebral cortex of patients with progressive supranuclear palsy. Neurosci Lett 1995;201:123-126.
49. Kertesz A, Hudson L, Mackenzie IRA, Munoz DG. The pathology and nosology of primary progressive aphasia. Neurology 1994;44:2065-2072.
50. Lang AE, Bergeron C, Pollanen MS, Ashby P. Parietal Pick's disease mimicking cortical-basal ganglionic degeneration. Neurology 1994;44:1436-1440.
51. Mizusawa H, Yen S-H, Hirano A, Llena JF. Pathology of the dentate nucleus in progressive supranuclear palsy: a histological, immunohistochemical and ultrastructural study. Acta Neuropathol (Berl) 1989;78:419-428.
52. Kobayashi K, Morikawa K, Fukutani Y, et al. Ramsey Hunt syndrome: progressive mental deterioration in association with unusual cerebral white matter change. Clin Neuropathol 1994;13:88-96.
53. Yamashita S, Iwamoto H, Hara M, et al. [Sisters with early onset hereditary dentatorubral-pallidoluysian atrophy of childhood-DNA analysis and clinicopathological findings]. (Japanese). No To Hattatsu 1995;27:473-479.
54. Kogure T, Oda T, Katoh Y. [Autopsy cases of hereditary ataxia pathologically diagnosed as the Japanese type of Joseph disease-cliniconeuropathological findings]. (Japanese). Seishin Shinkeigaku Zasshi 1990;92:161-183.
55. Iwabuchi K, Nagatomo H, Tanabe T, Sakai H, Yagishita S. [An autopsied case of type 2 Machado-Joseph's disease or spino-pontine degeneration). (Japanese). No To Shinkei 1993; 45:733-740.
56. Hattori H, Tanaka S, Kondoh H, Nishimura T, Hashimoto S. [A case of juvenile Alzheimer's disease with various neurological features such as myoclonus, showing grumose degeneration in the dentate nucleus]. (Japanese). Rinsho Shinkeigaku 1990;30:647-653.
57. Tabaton M, Rolleri M, Masturzo P, et al. Apolipoprotein E epsilon 4 allele frequency is not increased in progressive supranuclear palsy. Neurology 1995;45:1764-1765.
58. Farrer LA, Abraham CR, Volicer L, et al. Allele ∈4 of apolipoprotein E shows a dose effect on age at onset of Pick disease. Exp Neurol 1995;136:162-170.